LV
Algorae Pharmaceuticals Limited
LVCLF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $27.2M
P/E Ratio -
Div. Yield -
ROE 104.39%
Piotroski F-Score Weak
2/9Valuation
20 /100
Expensive P/B 6.39x
PEG N/A
P/E N/A
Growth
46 /100
Stable Book val. growth 4.19%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 63.39%
ROIC 67.00%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 25.11x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
19 /100
Unstable Profitable years 0
Beta -0.03x
EPS volatility 140.29%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LVCLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Richard Hainsworth
Employees
48
Headquarters
Melbourne